📣 VC round data is live. Check it out!
- Public Comps
- Median Technologies
Median Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Median Technologies and similar public comparables like Stratec, Affluent Medical, Orchestra BioMed, Asterasys and more.
Median Technologies Overview
About Median Technologies
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.
Founded
2002
HQ

Employees
164
Website
Financials (LTM)
EV
$243M
Valuation Multiples
Start free trialMedian Technologies Financials
Median Technologies reported last 12-month revenue of $29M and negative EBITDA of ($18M).
In the same LTM period, Median Technologies generated ($18M) in EBITDA losses and had net loss of ($31M).
Revenue (LTM)
Median Technologies P&L
In the most recent fiscal year, Median Technologies reported revenue of $27M and EBITDA of ($19M).
Median Technologies is unprofitable as of last fiscal year, with gross margin of 102%, EBITDA margin of (68%), and net margin of (145%).
Financial data powered by Morningstar, Inc.
Median Technologies Stock Performance
Median Technologies has current market cap of $239M, and enterprise value of $243M.
Market Cap Evolution
Median Technologies' stock price is $6.26.
Median Technologies share price increased by 10.9% in the last 30 days, and by 146.7% in the last year.
Median Technologies has an EPS (earnings per share) of $-1.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $243M | $239M | -2.0% | 10.9% | 9.3% | 146.7% | $-1.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedian Technologies Valuation Multiples
Median Technologies trades at 8.5x EV/Revenue multiple, and (13.2x) EV/EBITDA.
EV / Revenue (LTM)
Median Technologies Financial Valuation Multiples
As of May 23, 2026, Median Technologies has market cap of $239M and EV of $243M.
Median Technologies has a P/E ratio of (7.7x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Median Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Median Technologies Margins & Growth Rates
Median Technologies grew revenue by 13% but EBITDA decreased by 2% in the last fiscal year.
In the most recent fiscal year, Median Technologies reported gross margin of 102%, EBITDA margin of (68%), and net margin of (145%).
Median Technologies Margins
Median Technologies Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Median Technologies Operational KPIs
Median Technologies' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Median Technologies' Rule of 40 is (46%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Median Technologies' Rule of X is (26%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Median Technologies Competitors
Median Technologies competitors include Stratec, Affluent Medical, Orchestra BioMed, Asterasys, Humacyte, OraSure, Onward Medical, Quantum-Si, Ascom and Profound Medical.
Most Median Technologies public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.2x | 1.2x | 9.3x | 8.9x | |||
| — | 207.8x | — | (11.6x) | |||
| 4.9x | 8.0x | (3.2x) | (2.4x) | |||
| 9.0x | 7.7x | 27.2x | 22.3x | |||
| 121.8x | 60.2x | (11.2x) | — | |||
| 0.7x | 0.7x | (2.0x) | (2.1x) | |||
| 28.3x | 17.2x | (3.8x) | (3.2x) | |||
| 43.1x | 55.7x | (1.3x) | (1.2x) | |||
This data is available for Pro users. Sign up to see all Median Technologies competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Median Technologies
| When was Median Technologies founded? | Median Technologies was founded in 2002. |
| Where is Median Technologies headquartered? | Median Technologies is headquartered in France. |
| How many employees does Median Technologies have? | As of today, Median Technologies has over 164 employees. |
| Is Median Technologies publicly listed? | Yes, Median Technologies is a public company listed on Euronext Paris. |
| What is the stock symbol of Median Technologies? | Median Technologies trades under ALMDT ticker. |
| When did Median Technologies go public? | Median Technologies went public in 2011. |
| Who are competitors of Median Technologies? | Median Technologies main competitors include Stratec, Affluent Medical, Orchestra BioMed, Asterasys, Humacyte, OraSure, Onward Medical, Quantum-Si, Ascom, Profound Medical. |
| What is the current market cap of Median Technologies? | Median Technologies' current market cap is $239M. |
| What is the current revenue of Median Technologies? | Median Technologies' last 12 months revenue is $29M. |
| What is the current revenue growth of Median Technologies? | Median Technologies revenue growth (NTM/LTM) is 21%. |
| What is the current EV/Revenue multiple of Median Technologies? | Current revenue multiple of Median Technologies is 8.5x. |
| Is Median Technologies profitable? | No, Median Technologies is not profitable. |
| What is the current EBITDA of Median Technologies? | Median Technologies has negative EBITDA and is not profitable. |
| What is Median Technologies' EBITDA margin? | Median Technologies' last 12 months EBITDA margin is (64%). |
| What is the current EV/EBITDA multiple of Median Technologies? | Current EBITDA multiple of Median Technologies is (13.2x). |
| What is the current FCF of Median Technologies? | Median Technologies' last 12 months FCF is ($19M). |
| What is Median Technologies' FCF margin? | Median Technologies' last 12 months FCF margin is (68%). |
| What is the current EV/FCF multiple of Median Technologies? | Current FCF multiple of Median Technologies is (12.5x). |
| How many companies Median Technologies has acquired to date? | Median Technologies hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Median Technologies has invested to date? | Median Technologies hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Median Technologies
Lists including Median Technologies
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.